Posted by Michael Wonder on 01 Jun 2024
New analysis examines role of conditional approvals on access to promising oncology therapies
31 May 2024 - Health Canada’s Notice of Compliance with conditions (NOC/c) policy has been effective in providing people in Canada with faster access to new oncology drugs based on promising data.
A retrospective cohort analysis published in the Canadian Journal of Health Technologies substantiates this by reviewing the NOC/c approvals with a focus on the confirmatory study and time to confirmatory evidence submission, as well as how many of these therapies have become standard of care.
